Johnson & Johnson (J&J) reported better-than-expected adjusted earnings and revenue for the third quarter, showcasing strong performance in its pharmaceutical and medical devices bus… Read More
Cold and flu medicine including NyQuil sit on a store shelf in Miami on Sept. 12, 2023.
Joe Raedle | Getty Images
CVS is removing some of the most common cough and cold medicines fr… Read More
A Birkenstock banner hangs outside the New York Stock Exchange (NYSE) in New York on October 11, 2023, as Birkenstock launches an Initial Public Offering (IPO).
Angela Weiss | Afp… Read More
British chip design firm Arm has been gearing up to go public for quite some time, and now, the chipmaker has set the stage for one of the most significant initial public offerings (IPOs) of… Read More
A combination package of Procter & Gamble Co. DayQuil Severe and NyQuil Severe brand cold and flu medicine is arranged for a photograph in Tiskilwa, Illinois.
Daniel Acker | Bloombe… Read More
Johnson & Johnson plans to price shares of its consumer-health spinoff Kenvue at $20 to $23 in an initial public offering later this year. The spinoff, which would be valued at around $4… Read More
Thibaut Mongon, CEO of Kenvue Inc. a Johnson & Johnson’s consumer-health business, speaks during an interview to celebrate its IPO at the New York Stock Exchange (NYSE), May 4… Read More
Thibaut Mongon, CEO and Paul Ruh CFO of Kenvue Inc. a Johnson & Johnson’s consumer-health business, pose together during the company’s IPO at the New York Stock Exchange… Read More
Thibaut Mongon, CEO and Paul Ruh CFO of Kenvue Inc. a Johnson & Johnson’s consumer-health business, pose together during the company’s IPO at the New York Stock Exchange… Read More
2023 has been a pretty slow year as far as initial public offerings go, but pharmaceutical giant Johnson & Johnson (
JNJ, Financial) bucked the trend on Thursday by offering its consume… Read More
New Jersey: Johnson & Johnson said on Monday it was seeking a valuation of up to $42.95 billion in the initial public offering of its consumer health unit, Kenvue, at a time when in… Read More
As markets open for the new year, a mega breakup that could shake up the consumer healthcare market is coming down the initial public offering (IPO) pipeline.
Johnson & Johnson (J&J)… Read More